Elsevier

Cancer Treatment Reviews

Volume 34, Issue 8, December 2008, Pages 682-692
Cancer Treatment Reviews

Hot Topic
The kisspeptin (KiSS-1)/GPR54 system in cancer biology

https://doi.org/10.1016/j.ctrv.2008.05.007Get rights and content

Summary

Kisspeptin (KiSS-1) gene, initially described as a melanoma metastasis suppressor gene, encodes a number of peptides (kp-54, kp-14, kp-13, kp-10), which are endogenous ligands to a G protein-coupled receptor, referred as hOT7T175 or AXOR12 or GPR54. So far intensive investigation has provided substantiate evidence supporting the role of KiSS-1/GPR54 system in cancer biology as well as in the regulation of the reproductive function and trophoblast invasion. The precise mechanism by which KiSS-1/GPR54 system is affecting cancer cell growth and metastasis includes complex endocrine, paracrine and autocrine actions. Nevertheless, the detail mechanism of such actions is still under intensive investigation. Herein we review the evidence which support the role of KiSS-1/GPR54 system in cancer biology.

Introduction

Metastasis is a complex multistep process, which includes loss of cell–cell adhesion within neoplastic epithelium, invasion of surrounding tissues, angiogenesis and dissemination of cancer cells through vascular and lymphatic vessels, trans passing through vascular endothelium into distant sites (host tissues).1, 2 Nowadays, cancer research is focusing on the blockade of the metastatic process at its early steps.3, 4 Therefore, there is growing interest in identifying metastasis suppressor genes, which may be involved in the control of cancer cell dissemination. In this context, KiSS-1 was initially discovered by Lee et al. (1996) in experiments designed to identify the molecules responsible for the antimetastatic effect of human chromosome 6. Using subtractive hybridization and differential display, the researchers isolated seven cDNA clones that exhibited higher expression in neo6/melanoma hybrids. One of these clones, designated KiSS-1, suppressed metastasis in two human malignant melanoma cell lines.5 So far, data have analyzed the regulation of kisspeptins secretion and have provided strong evidence for the participation for these molecules in several biological processes.

The main kisspeptin functions which have been thoroughly investigated are the following: Kisspeptin and reproductive axis and puberty: The possible connection of kisspeptin system and pubertal development was revealed in 2003, when humans and mice with GPR54 mutations6 were found to suffer from hypogonadotropic hypogonadism, characterized by absence of sexual maturation and decreased levels of sex hormones and gonadotropins. Interestingly, a GPR54-activating mutation was found in a patient with central precocious puberty.7 Polymorphism scans of the KiSS-1 and GPR54 genes in Chinese girls with central precocious puberty revealed a nonsynonymous single nucleotide polymorphism in the KiSS-1 gene and a SNP (nonsynonymous mutation) in the promoter region of the GPR54 gene, that were statistically related to the disease.8, 9 Further evidence, have supported the crucial role of KiSS-1/GPR54 system in reproductive function, which included the stimulation of LH release after in vivo administration of kisspeptin in mammals10, 11 as well as the implication of kisspeptin in mediating the estrogen positive and negative feedback in gonadotropin secretion.12, 13, 14 Moreover, the KiSS-1/GPR54 system has a distinct role in the seasonal (photoperiodic) control of reproduction as well as in the integration between energy status and reproduction (Fig. 1). Revel et al. 2007, have studied the photoneuroendocrine system in Syrian hamsters and concluded that the unknown – so far – link between the melatonin secretion and reproduction is the KiSS-1/GPR54 system.15 As far as the metabolic control of reproduction is concerned, it was observed that while the hypothalamic KiSS-1 gene expression is diminished during states of negative energy balance; kisspeptin administration overcomes the hypogonadotropic state seen in such conditions, an action thought to be mediated by leptin.16, 17, 18

Kisspeptin and placenta/trophoblasts: Kisspeptin was also involved in the procedure of placentation and trophoblast invasion. Recent studies have shown that kisspeptin repressed the invasion of the trophoblast into the maternal deciduas,19, 20 an essential process for fetal development, which so closely mimics the invasion of cancer cells (hence the normal trophoblast has been termed “pseudomalignant”). Measurements throughout pregnancy have revealed a dramatic increase of the circulating kisspeptin levels, which returned to near baseline levels, by day 5 postpartum, suggesting that the placenta produces kisspeptin during pregnancy.21 While the precise role of kisspeptin in pregnancy is still unknown, it is thought that it probably mediates the down regulation of the hypothalamic-pituitary-gonadal (HPG) axis.22 Quantitative polymerase chain reaction (PCR) analysis and laser capture microdissection revealed higher GPR54 expression levels in early placentas (where the invasive capacity of trophoblasts needs to be tightly controlled) as compared to term placentas.23 Moreover, KiSS-1/GPR54 role in the pathogenesis of pre-eclampsia has been recently proposed, but the existing data report rather conflicting results. Thus, according to Qiao et al. 2005 and Zhang et al. 2006, higher kisspeptin levels along with decreased matrix metalloproteinase 9 (MMP-9) are detected in pre-eclampsia while another study has reported decreased KiSS-1 levels in the placental tissues of pre-eclampsia.24, 25, 26

Furthermore, recent data suggested the possible role for these molecules in other previously unsuspected pathologies: Kisspeptin and polycystic ovarian syndrome (PCOS): Panidis et al. 2006, measured the circulating kp-54 (referred also as metastin) levels in 28 obese women with PCOS, 28 normal weight women with the syndrome, and 13 obese controls and found that the obese-PCOS group had the lowest kp-54 levels compared to normal weight women with PCOS and obese controls. However, plasma kp-54 immunoreactive (IR) concentrations were not significantly different in women with PCOS compared to controls. Furthermore, plasma kp-54 levels were found to be negatively correlated with body mass index (BMI), free androgen index, and indices of insulin resistance.27Kisspeptin and cardiovascular system: Mead et al. 2006, described a potent vasoconstrictor action of kisspeptins in isolated rings of coronary artery and umbilical vein.28Kisspeptin and diabetes: Hauge-Evans et al. 2006, detected expression of the KiSS-1/GPR54 system in the endocrine pancreas and reported the stimulation of glucose-induced insulin secretion when human and mouse islets are exposed to kisspeptin.29 Castellano et al. 2006, after conducting experiments in diabetic male rats, propose a role for the KiSS-1/GPR54 system in the altered gonadotropin secretion of type 1 diabetes.30Kisspeptin and menopause: Rometo et al. 2007, observed that menopause is associated with increased hypothalamic kisspeptin expression.31

Section snippets

KiSS-1/GPR54 system in cancer

The KiSS-1 gene is located on chromosome 1 (Fig. 2), with regulatory elements localized in chromosome 6 (to the 40 cM region between D6S468 and D6S314 in 6q16.3–q23).5, 32 KiSS-1 and GPR54 genes are mainly expressed in the placenta but also are found in the central nervous system (CNS), testis, ovary, pancreas and intestine (Table 1). The primary translation product of the KiSS-1 gene is a largely hydrophobic 145 amino acid polypeptide, known as kisspeptin. This peptide produces by proteolytic

Future investigation

There exist strong data to suggest that KiSS-1 is a metastasis suppressor in melanoma, bladder cancer, gastric carcinoma, esophageal cancer, thyroid cancer, epithelial ovarian cancer, endometrial cancer, choriocarcinoma, pancreatic cancer and uveal melanoma. Several studies so far have supported a strong correlation between lack of KiSS-1 expression and poor clinical outcome. However, there are two types of human malignancies, in which high rather than low KiSS-1 expression is associated to

References (105)

  • K. Hata et al.

    Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer

    Eur J Cancer

    (2007)
  • M. Sanchez-Carbayo et al.

    Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome

    Am J Pathol

    (2003)
  • M. Sanchez-Carbayo et al.

    Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genes

    Lab Invest

    (2003)
  • C. Yan et al.

    KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha-induced block of p65/p50 nuclear translocation

    J Biol Chem

    (2001)
  • M. Koutsilieris

    Skeletal metastases in advanced prostate cancer: cell biology and therapy

    Crit Rev Oncol Hematol

    (1995)
  • M. Koutsilieris et al.

    Mitogen(s) for endometrial-like cells can be detected in human peritoneal fluid

    Fertil Steril

    (1991)
  • M. Koutsilieris et al.

    Heparin–sepharose binding growth factors in peritoneal fluid of women with endometriosis

    Fertil Steril

    (1993)
  • S. Zucker et al.

    Membrane type-matrix metalloproteinases (MT-MMP)

    Curr Top Dev Biol

    (2003)
  • M. Koutsilieris et al.

    The molecular concept of prostate cancer

    Cancer J

    (1996)
  • M. Koutsilieris et al.

    The assessment of disease aggressivity in stage D2 prostate cancer patients (review)

    Anticancer Res

    (1990)
  • J. Bogdanos et al.

    Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton

    Endocr Relat Cancer

    (2003)
  • M. Koutsilieris et al.

    Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: case report

    Prostate

    (1999)
  • J.H. Lee et al.

    KiSS-1, a novel human malignant melanoma metastasis-suppressor gene

    J Natl Cancer Inst

    (1996)
  • S.B. Seminara et al.

    The GPR54 gene as a regulator of puberty

    N Engl J Med

    (2003)
  • M.G. Teles et al.

    A GPR54-activating mutation in a patient with central precocious puberty

    N Engl J Med

    (2008)
  • X. Luan et al.

    GPR54 polymorphisms in Chinese girls with central precocious puberty

    Neuroendocrinology

    (2007)
  • X. Luan et al.

    Association study of the polymorphisms in the KISS1 gene with central precocious puberty in Chinese girls

    Eur J Endocrinol

    (2007)
  • M.L. Gottsch et al.

    A role for kisspeptins in the regulation of gonadotropin secretion in the mouse

    Endocrinology

    (2004)
  • M. Shahab et al.

    Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates

    Proc Natl Acad Sci USA

    (2005)
  • S. Adachi et al.

    Involvement of anteroventral periventricular metastin/kisspeptin neurons in estrogen positive feedback action on luteinizing hormone release in female rats

    J Reprod Dev

    (2007)
  • K. Maeda et al.

    Metastin/kisspeptin and control of estrous cycle in rats

    Rev Endocr Metab Disord

    (2007)
  • F.G. Revel et al.

    Kisspeptin: a key link to seasonal breeding

    Rev Endocr Metab Disord

    (2007)
  • D. Blache et al.

    Dynamic and integrative aspects of the regulation of reproduction by metabolic status in male sheep

    Reprod Nutr Dev

    (2006)
  • M. Tena-Sempere

    KiSS-1 and reproduction: focus on its role in the metabolic regulation of fertility

    Neuroendocrinology

    (2006)
  • M. Bilban et al.

    Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts

    J Cell Sci

    (2004)
  • U. Hiden et al.

    Kisspeptins and the placenta: regulation of trophoblast invasion

    Rev Endocr Metab Disord

    (2007)
  • Y. Horikoshi et al.

    Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans

    J Clin Endocrinol Metab

    (2003)
  • W.S. Dhillo et al.

    The neuroendocrine physiology of kisspeptin in the human

    Rev Endocr Metab Disord

    (2007)
  • J.L. Janneau et al.

    Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells

    J Clin Endocrinol Metab

    (2002)
  • A. Farina et al.

    Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls

    Prenatal Diag

    (2006)
  • M. Gaytan et al.

    Expression of KiSS-1 in rat oviduct: possible involvement in prevention of ectopic implantation?

    Cell Tissue Res

    (2007)
  • C. Qiao et al.

    Clinical significance of KiSS-1 and matrix metalloproteinase-9 expression in trophoblasts of women with preeclampsia and their relation to perinatal outcome of neonates

    Zhonghua Fu Chan Ke Za Zhi

    (2005)
  • E.J. Mead et al.

    Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosis-prone vessels

    Endocrinology

    (2007)
  • A.C. Hauge-Evans et al.

    A role for kisspeptin in islet function

    Diabetologia

    (2006)
  • J.M. Castellano et al.

    Expression of hypothalamic KiSS-1 system and rescue of defective gonadotropic responses by kisspeptin in streptozotocin-induced diabetic male rats

    Diabetes

    (2006)
  • A.M. Rometo et al.

    Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys

    J Clin Endocrinol Metab

    (2007)
  • M.E. Miele et al.

    A human melanoma metastasis-suppressor locus maps to 6q16.3–q23

    Int J Cancer

    (2000)
  • K.G. Murphy

    Kisspeptins: regulators of metastasis and the hypothalamic-pituitary-gonadal axis

    J Neuroendocrinol

    (2005)
  • G.J. Dockray

    The expanding family of –RFamide peptides and their effects on feeding behaviour

    Exp Physiol

    (2004)
  • T. Ohtaki et al.

    Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor

    Nature

    (2001)
  • Cited by (0)

    View full text